Team Topicure!

We are not just researchers, we are problem- solvers!

We are a passionate collective of scientists, clinicians, and innovators united by a single mission: to revolutionize the fight against antimicrobial resistance. Driven by the desire to turn cutting-edge discoveries into meaningful clinical outcomes, we combine advanced biotechnology with hands-on medical expertise to develop next-generation topical therapies that are precise, effective, and built for real-world healing.

 

Dr. Saffron Bryant

Co founder & Chief Scientific Officer (CSO)

Dr. Bryant brings a unique blend of scientific expertise and entrepreneurial experience to Team Topicure. With a strong background in advanced materials, eutectogels, and bio-activity assays, she plays a pivotal role in the development and evaluation of our core technologies. Beyond the lab, Dr. Bryant’s business acumen and leadership guide TopiCure’s strategic vision, helping transform innovative research into commercially viable solutions with real-world impact.

saffron.bryant@rmit.edu.au

Associate Professor Aaron Elbourne

Co founder & Chief Technology Officer (CTO)

A/Prof. Elbourne is a leading researcher in antimicrobial resistance (AMR) and novel nanomaterials for biomedical applications. With a deep understanding of material-microbe interactions, he leads TopiCure’s efforts in designing smart, responsive surfaces and gels that target multi-drug-resistant pathogens. His work bridges the gap between cutting-edge materials science and clinical microbiology, ensuring that our solutions are not just innovative, but also biologically effective and clinically relevant.

aaron.elbourne@rmit.edu.au

Dr. Shreehari Kodakkat

Co founder & HoP (Head of Product)

Dr. Shreehari Kodakkat is a clinician-scientist specializing in dental health, oral infections, and microbial assay development. With hands-on experience in translational dental research, he ensures that TopiCure’s technologies align with the needs of clinicians and patients alike. His expertise in peri-implantitis, biofilm modeling, and oral microbiome dynamics plays a crucial role in validating the efficacy of our topical formulations in real-world, infection-prone environments.

shreehari.kodakkat.unnikrishnan@rmit.edu.au